Novavax Faces Shareholder Pressure for Sale
Update: 2025-11-12
Description
Shah Capital, a major Novavax shareholder, is pushing for significant changes, including a potential sale, due to disappointing COVID-19 vaccine sales and frustration with the companys performance. Theyve warned of a proxy fight if demands arent met within four months, urging Novavax to form a committee to explore a sale and hire an investment bank.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
